Home › Amyotrophic Lateral Sclerosis › Michigan › Ann Arbor
Amyotrophic Lateral Sclerosis clinical trials in Ann Arbor, MI
7 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- University of Michigan, Ann Arbor
ASSESS ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- University of Michigan, Ann Arbor
PREVENT ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- University of Michigan, Ann Arbor
Study of COYA 302 for the Treatment of ALS
RecruitingPhase 2/3
- University of Michigan, Ann Arbor
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RecruitingObservational studyHealthy volunteers welcome
- University of Michigan, Ann Arbor
EIM Via the Myolex mScan as an ALS Biomarker
RecruitingObservational study
- University of Michigan, Ann Arbor
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Recruiting
- University of Michigan, Ann Arbor
About Amyotrophic Lateral Sclerosis
ALS stands for Amyotrophic Lateral Sclerosis, also called Lou Gehrig's disease. ALS affects the nervous system, causing muscle problems. Find out how.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Philadelphia, PA14 studies
- Jacksonville, FL13 studies
- Baltimore, MD13 studies
- New York City, NY11 studies
- San Diego, CA10 studies
- Chicago, IL10 studies
- San Francisco, CA10 studies
- St. Louis, MO9 studies
- Dallas, TX8 studies
- Phoenix, AZ8 studies
- Atlanta, GA8 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.